APP and Alzheimer disease: VDAC1 overexpression in the neuronal terminals surrounding the Aβ plaques in this study, and in AD brains, APP mouse brains, and Aβ-treated cells reported in previous studies [31, 32, 102], may result from VDAC1 promoter activation by Aβ.